activemixedsec_filings

CLSK 10-Q report for 2026-03-31

This play tracks CleanSpark’s 10‑Q filing for the quarter ended March 31, 2026. The available excerpt is the SEC cover page and identifies the company, listing, and that both common stock and redeemable warrants are described. No financial statements, MD&A, guidance, or detailed footnote disclosures were included in the excerpt. Primary near-term relevance: monitor warrant terms, outstanding count (when disclosed), potential dilution, and any subsequent filings or full 10‑Q content that provide quantifiable impacts.

Confidence
24 / 100
Assets
2
Authors
1
Outcome
open

Linked assets

CLSK — CleanSpark, Inc. common stock. CLSKW — CleanSpark redeemable warrants. The excerpt lists the securities and basic exercise/description language but does not provide the warrant count, fair value, redemption triggers, or other footnote detail required to quantify dilution or overhang.

CLSKriskopen

CleanSpark, Inc. common stock (CLSK). The excerpt is limited to cover-page filing metadata and identifies common stock as a reported security but contains no operating or financial detail.

Confidence: 25 / 100Start: $14.30Latest: $15.97Return: -11.68%

Only warrant existence/terms are shown here; without the full 10-Q footnotes (warrant count, fair value, redemption provisions), impact cannot be quantified.

CLSKWholdopen

CleanSpark redeemable warrants (CLSKW). The filing header references redeemable warrants and basic exercise terms but omits counts and footnote detail.

Confidence: 20 / 100

Terms are partially provided, but there is insufficient information in the excerpt to assess valuation versus underlying or redemption risk.

Source proof

Source proof: Strong source proof | 4 extracted claims | 1 directional asset | 1 supporting author | headline-like title review

The provided source text is the SEC cover page/filing header for CleanSpark’s Form 10‑Q for the period ended March 31, 2026. It confirms the company filed a 10‑Q but contains no financial results, MD&A, liquidity metrics, risk-factor updates, or detailed disclosures. As a result, the excerpt is not directly actionable beyond capital‑structure monitoring.

SNBR 10-Q report for 2026-04-04
Sleep Number Corp · May 12, 2026, 3:06 AM EDT

This excerpt is only the cover page/header of Sleep Number’s Form 10-Q for the quarter ended April 4, 2026. It contains filing metadata (issuer, ticker, exchange, address) but no financial statements, MD&A, guidance, risks, or operational commentary. As a result, it is not directly actionable for trading beyond confirming the filing exists.

View source
SOUN 10-Q report for 2026-03-31
SOUNDHOUND AI, INC. · May 11, 2026, 5:28 PM EDT

The provided excerpt is only the cover/filing header of SoundHound AI, Inc.’s 10‑Q for the quarter ended 2026‑03‑31. It contains listing/security identifiers (SOUN, SOUNW) but no financial statements, MD&A, guidance, risk updates, liquidity details, or material events. As a result, there is insufficient information to form high-confidence, actionable bullish/bearish theses beyond generic “company filed its 10‑Q” metadata.

View source
WEAT 10-Q report for 2026-03-31
Teucrium Commodity Trust · May 11, 2026, 5:19 PM EDT

The provided excerpt is only the boilerplate cover/filing-status section of Teucrium Commodity Trust’s Form 10‑Q for period ended 2026‑03‑31, with no portfolio holdings, performance, risk, or material updates included. As-is, it contains no actionable investment information beyond confirming the existence of the filing and the issuer/ticker identity (WEAT).

View source
ACHR 10-Q report for 2026-03-31
Archer Aviation Inc. · May 11, 2026, 5:01 PM EDT

The provided text is only the cover page of Archer Aviation’s Form 10‑Q for the quarter ended 2026‑03‑31 (issuer identity, exchange listing, and securities outstanding). It contains no operating/financial results, guidance, liquidity details, backlog, or risk-factor updates—so it is minimally actionable for trading beyond basic security identifiers and a generic dilution/optionality consideration from warrants.

View source
CLSK 10-Q report for 2026-03-31
CLEANSPARK, INC. · May 11, 2026, 4:58 PM EDT

This excerpt is essentially the cover page of CleanSpark, Inc.’s Form 10-Q for the quarter ended March 31, 2026. It contains identifiers (CIK/file no.), listing venue, and security descriptions (common stock and redeemable warrants with specific exercise terms), but no operating/financial results, guidance, risks, or MD&A detail. Actionability is therefore limited to capital-structure/dilution considerations around the listed warrant.

View source
ASTS 10-Q report for 2026-03-31
AST SpaceMobile, Inc. · May 11, 2026, 4:40 PM EDT

This excerpt of AST SpaceMobile’s 10‑Q is largely SEC cover-page/boilerplate (registrant info, exchange listing, filing compliance) and contains no financial results, guidance, liquidity, risk-factor updates, or operating metrics. As provided, it does not create a clear tradable catalyst beyond confirming continued reporting/listing status.

View source
SMCI 10-Q report for 2026-03-31
Super Micro Computer, Inc. · May 11, 2026, 4:38 PM EDT

This excerpt only includes the cover page of Super Micro Computer, Inc.’s Form 10‑Q for the quarter ended March 31, 2026. It confirms the filing, issuer identity, listing (Nasdaq), and ticker (SMCI), but contains no financial results, guidance, risks, or MD&A content to support a directional investment view.

View source
ABCL 10-Q report for 2026-03-31
AbCellera Biologics Inc. · May 11, 2026, 4:18 PM EDT

The provided text is only the cover/header portion of AbCellera Biologics Inc.’s Form 10‑Q for the quarter ended March 31, 2026 (identifying info, exchange listing, filing status). It contains no financial statements, guidance, risk updates, material events, MD&A, cash runway, pipeline/program updates, or disclosures that would support a differentiated trading view.

View source

Supporting authors

Single-author extraction. Analysis focuses on informational limits of a cover-page excerpt and highlights the need to retrieve the full 10‑Q (including notes and MD&A) to assess dilution, warrant valuation, and liquidity implications.

Unlock full thesis monitoring

Action: pull the full Form 10‑Q and footnotes for CLSK to determine number of outstanding warrants, exercise prices, redemption provisions, and any changes to share count or liquidity. Monitor subsequent filings or company statements for warrant exercises, conversions, or capital raises that could affect dilution.